Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Department of Defense (DoD) office of Congressionally Directed Medical Research Programs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE